Kristin Eivindvik
Plus aucun poste en cours
Profil
Kristin Eivindvik worked as a Director-Global Project at GE Healthcare AS, Vice President-Operations at Alertis Medical AS, and Chief Development Officer at PCI Biotech Holding ASA. She is a graduate of the University of Oslo.
Anciens postes connus de Kristin Eivindvik
| Sociétés | Poste | Fin |
|---|---|---|
| PCI BIOTECH HOLDING ASA | Corporate Officer/Principal | - |
GE Healthcare AS
 GE Healthcare AS Medical SpecialtiesHealth Technology GE Healthcare AS markets contrast agent for x-ray, ultrasound, Magnetic Resonance Imaging, and radiopharmaceuticals for clinicians to predict, diagnose, inform, and treat diseases. The company was founded on September 07, 1981 and it is headquartered in Oslo, Norway. | Corporate Officer/Principal | - |
Alertis Medical AS
 Alertis Medical AS Medical DistributorsDistribution Services Alertis Medical AS was established in 2000 to develop and commercialize a unique technology for the early detection of critical conditions related to blood supply and respiration, addressing considerable unmet needs in medicine. The patented technology originates from the anesthesiologist Prof T. I. Tønnessen, MD, PhD, and the physicist P. Mirtaheri, PhD, at Rikshospitalet University Hospital, Oslo | Chief Operating Officer | - |
Formation de Kristin Eivindvik
| University of Oslo | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PCI BIOTECH HOLDING ASA | Health Technology |
| Entreprise privées | 2 |
|---|---|
GE Healthcare AS
GE Healthcare AS Medical SpecialtiesHealth Technology GE Healthcare AS markets contrast agent for x-ray, ultrasound, Magnetic Resonance Imaging, and radiopharmaceuticals for clinicians to predict, diagnose, inform, and treat diseases. The company was founded on September 07, 1981 and it is headquartered in Oslo, Norway. | Health Technology |
Alertis Medical AS
Alertis Medical AS Medical DistributorsDistribution Services Alertis Medical AS was established in 2000 to develop and commercialize a unique technology for the early detection of critical conditions related to blood supply and respiration, addressing considerable unmet needs in medicine. The patented technology originates from the anesthesiologist Prof T. I. Tønnessen, MD, PhD, and the physicist P. Mirtaheri, PhD, at Rikshospitalet University Hospital, Oslo | Distribution Services |
